What does it mean that marijuana rescheduling was blocked in 2026?

Congress passed a resolution under the Congressional Review Act to stop the DEA from moving cannabis from Schedule I to Schedule III. This means cannabis remains a federally illegal substance with no recognized medical use, and the rescheduling process is effectively halted unless the president vetoes the resolution and Congress overrides it.

Will this block affect state-legal cannabis markets?

Not immediately. State-legal programs in places like California, Colorado, and Michigan continue operating under existing state laws. However, the block means federal protections like banking access and tax relief remain off the table, keeping the industry in a cash-only, high-tax environment.

Can President Trump override the block?

President Trump can veto the Congressional Review Act resolution, but then Congress would need a two-thirds majority in both chambers to override the veto. Given the narrow margins in the Senate, an override is unlikely, so the block will likely stand unless the administration restarts the rescheduling process from scratch.

What happens next for federal cannabis reform?

The immediate focus shifts to standalone bills like the SAFE Banking Act and the MORE Act, though both face steep odds without bipartisan support. State-level reform will accelerate, with states like California and Florida moving ahead independently. The rescheduling block may also push advocates to pursue federal legalization via ballot initiatives or a new administration in 2028.

Marijuana Rescheduling Blocked 2026: Congress vs. Trump

The White House wanted to move weed to Schedule III. Congress just said, 'Not so fast.'

On Tuesday, May 12, 2026, a bipartisan coalition in the U.S. House of Representatives voted 267-158 to block the Trump administration’s proposed rule to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act. The marijuana rescheduling blocked 2026 decision marks the most significant federal cannabis policy reversal in over a decade — and it has the industry, patients, and state regulators scrambling to figure out what happens next.

The Backstory: How We Got Here

Back in August 2025, President Trump — fresh off a campaign promise to 'let the states decide' — directed the DEA and HHS to initiate formal rulemaking to reschedule cannabis. By November 2025, the DEA had published a proposed rule moving cannabis to Schedule III, citing medical utility and lower abuse potential. The comment period was a mess: over 2 million submissions, including a flood of opposition from prohibitionist groups and even some cannabis companies worried about 280E tax implications.

But here’s the twist: the Trump administration’s own Department of Justice quietly flagged internal concerns about the rescheduling process, worrying it would conflict with international treaty obligations. Those concerns never went public — until now.

The Congressional Maneuver That Stalled It All

Representatives Bob Good (R-VA) and Debbie Dingell (D-MI) co-sponsored a joint resolution of disapproval under the Congressional Review Act (CRA). The resolution argued that rescheduling cannabis without explicit congressional authorization exceeded the DEA’s statutory authority. The CRA allows Congress to overturn federal agency rules with a simple majority — and that’s exactly what happened.

The vote wasn’t even close. 58 Democrats joined 209 Republicans to approve the resolution. Only 126 Democrats and 32 Republicans opposed it. The Senate is expected to take up an identical resolution by June 1, and with a 54-46 GOP majority, passage is likely. If President Trump vetoes it (which he has threatened to do), both chambers would need a two-thirds majority to override — a steep climb.

Immediate Fallout: What Changes (and What Doesn’t)

For now, cannabis remains a Schedule I substance, defined as having 'no accepted medical use and a high potential for abuse.' That means:

280E tax penalty stays. State-legal cannabis businesses cannot deduct ordinary business expenses, crushing profit margins. A 2024 study from the Cannabis Tax Coalition estimated that 280E cost the industry $1.8 billion in extra taxes in 2025 alone.
No banking reform. SAFE Banking is still stalled in committee. Rescheduling would have allowed credit unions and banks to serve cannabis businesses without federal penalty. Now, cash-only operations remain the norm in most states.
Research restrictions remain. Schedule I status means universities and research institutes need DEA registration to study cannabis. Only four universities currently hold Schedule I research licenses.
State-legal markets keep running. The DOJ has not signaled any intent to crack down on state-legal programs. But the rescheduling block creates a confusing patchwork: states like California, Colorado, and Michigan are fully legal, while federal law still classifies their products as illegal.

Why Did Some Democrats Vote to Block?

It’s easy to assume this is just Republican obstructionism, but the vote was more complicated. Representative Dingell, a progressive from Michigan, argued that rescheduling via executive action would 'short-circuit' the legislative process and could lead to weaker medical protections. 'We need a comprehensive bill, not a band-aid,' she said on the House floor.

Meanwhile, some Democrats — including several from swing districts — worried about political backlash. Polling from Pew Research in April 2026 showed that 62% of Americans support full legalization, but only 48% support rescheduling. The difference? Many voters don’t understand what rescheduling actually does, and prohibitionist groups ran ads claiming it would 'make marijuana as easy to get as aspirin.'

The Trump Administration Strikes Back

President Trump responded swiftly. On Wednesday, May 13, he issued a statement calling the vote 'a betrayal of states’ rights and common sense.' White House Press Secretary Karoline Leavitt confirmed that the president would veto any CRA resolution that lands on his desk. 'Rescheduling is the right policy, and we will fight for it,' she said.

But Trump’s leverage is limited. If Congress passes the CRA resolution and he vetoes it, the rule still stays blocked until the override vote. If the override fails, the administration could theoretically restart the rescheduling process from scratch — but that would take at least 18 months, pushing any final rule into 2028.

What’s Next for Cannabis Policy?

Legislative Path

- SAFE Banking Act is expected to get a standalone vote in the Senate in June, but without rescheduling, it faces an uphill climb. The American Bankers Association has said it won’t support SAFE without Schedule III status. - The MORE Act (full federal legalization) has been reintroduced by Rep. Jerry Nadler (D-NY), but it has zero Republican co-sponsors this session.

State-Level Action

- California just passed SB 1427, creating a state-run cannabis import-export program that will launch in 2027 — a direct challenge to federal law. - Florida is fast-tracking adult-use licenses after the 2024 ballot initiative passed. - Texas is expanding its medical program, but Gov. Abbott has publicly said he will not support legalization without federal rescheduling.

What This Means For You

If you’re a cannabis consumer, patient, or business owner, here’s the bottom line:

Your local dispensary isn’t going anywhere. State-legal markets are protected by the Cole Memorandum-era guidance that the DOJ hasn’t rescinded. But don’t expect federal protections anytime soon.
Prices won’t drop. Without rescheduling, the 280E tax burden keeps retail prices high. Expect $300+ ounces in legal states for the foreseeable future.
Medical patients lose. Schedule I status means no federal recognition of cannabis as medicine. If you rely on medical cannabis for chronic pain, PTSD, or epilepsy, you’re still stuck paying cash and hoping your state program doesn’t get raided.
Grow your own if you can. In states where home cultivation is legal (California, Colorado, Maine, Michigan, etc.), grow your own medicine. Check out seeds from ILGM or Seedsman for reliable genetics.
Vote. The 2026 midterms are in November. Candidates who support rescheduling — or full legalization — need your support. The cannabis industry has over 500,000 employees now. That’s a voting bloc worth paying attention to.

This fight isn’t over. The marijuana rescheduling blocked 2026 moment is a speed bump, not a dead end. But it’s a reminder that federal cannabis reform is never a done deal — even when both parties seem to agree. Stay informed, stay engaged, and keep your stash ready.

*— Angelica M., Senior Writer, StrainHub*

Congress Blocks Marijuana Rescheduling: What It Means